Tata Capital Healthcare Fund II infuses USD 10 million in Apex Kidney Care
Tata Capital, a prominent private equity (PE) firm, has announced a substantial investment of USD 10 million in Mumbai-based dialysis chain Apex Kidney Care (AKC), securing an undisclosed equity stake in the process.
This funding has been channeled through Tata Capital Healthcare Fund II (TCHF II), a private equity fund with a specific focus on the healthcare sector.
As per various media reports, out of the USD 10 million investment, approximately 90% will be allocated for fueling the growth of Apex Kidney Care, while the remaining 10% will provide an exit opportunity for specific angel investors. Founded by nephrologists Jatin Kothari and Viswanath Billa, AKC has garnered financial support from both its founders and angel investors.
For more details, check out the link given below:
Tata Capital Health Division Pours USD 10 Million Investment Into Apex Kidney Care
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.